Aldebaran Financial Inc. boosted its stake in MetLife, Inc. (NYSE:MET) by 1.2% during the first quarter, according to its most recent filing with the SEC. The firm owned 34,321 shares of the financial services provider’s stock after buying an additional 400 shares during the period. MetLife comprises 1.4% of Aldebaran Financial Inc.’s portfolio, making the stock its 25th largest position. Aldebaran Financial Inc.’s holdings in MetLife were worth $1,813,000 at the end of the most recent quarter.

Other large investors have also recently modified their holdings of the company. BlackRock Inc. boosted its stake in shares of MetLife by 3,323.3% in the first quarter. BlackRock Inc. now owns 68,475,870 shares of the financial services provider’s stock valued at $3,616,895,000 after buying an additional 66,475,603 shares during the period. Vanguard Group Inc. boosted its stake in shares of MetLife by 3.0% in the first quarter. Vanguard Group Inc. now owns 65,364,620 shares of the financial services provider’s stock valued at $3,452,559,000 after buying an additional 1,885,246 shares during the period. State Street Corp boosted its stake in shares of MetLife by 1.4% in the first quarter. State Street Corp now owns 49,020,964 shares of the financial services provider’s stock valued at $2,589,297,000 after buying an additional 680,903 shares during the period. Geode Capital Management LLC boosted its stake in shares of MetLife by 6.9% in the first quarter. Geode Capital Management LLC now owns 10,265,096 shares of the financial services provider’s stock valued at $541,427,000 after buying an additional 664,918 shares during the period. Finally, Morgan Stanley boosted its stake in shares of MetLife by 5.4% in the first quarter. Morgan Stanley now owns 7,946,397 shares of the financial services provider’s stock valued at $419,728,000 after buying an additional 404,104 shares during the period. 74.83% of the stock is currently owned by hedge funds and other institutional investors.

Shares of MetLife, Inc. (NYSE MET) traded up 0.5702% on Tuesday, hitting $48.8067. The company’s stock had a trading volume of 1,805,295 shares. The firm has a market cap of $53.07 billion, a price-to-earnings ratio of 548.3899 and a beta of 1.46. MetLife, Inc. has a one year low of $38.87 and a one year high of $58.09. The stock has a 50-day moving average price of $54.59 and a 200 day moving average price of $53.07.

MetLife (NYSE:MET) last announced its quarterly earnings results on Wednesday, August 2nd. The financial services provider reported $1.30 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $1.28 by $0.02. The business had revenue of $17.39 billion during the quarter, compared to the consensus estimate of $17.11 billion. MetLife had a net margin of 0.30% and a return on equity of 8.51%. The business’s revenue was up 2.5% compared to the same quarter last year. During the same quarter last year, the firm earned $0.83 EPS. Equities research analysts predict that MetLife, Inc. will post $4.97 EPS for the current year.

The company also recently declared a quarterly dividend, which will be paid on Wednesday, September 13th. Stockholders of record on Monday, August 7th will be issued a dividend of $0.40 per share. The ex-dividend date is Thursday, August 3rd. This represents a $1.60 dividend on an annualized basis and a dividend yield of 3.30%. MetLife’s dividend payout ratio is currently 1,777.98%.

ILLEGAL ACTIVITY WARNING: This piece of content was originally posted by Daily Political and is owned by of Daily Political. If you are accessing this piece of content on another domain, it was illegally copied and republished in violation of U.S. and international trademark & copyright law. The legal version of this piece of content can be viewed at https://www.dailypolitical.com/2017/08/08/aldebaran-financial-inc-raises-stake-in-metlife-inc-nysemet.html.

MET has been the topic of several research reports. TheStreet cut MetLife from a “b-” rating to a “c” rating in a report on Tuesday, May 16th. Royal Bank Of Canada reaffirmed a “buy” rating and issued a $62.00 target price on shares of MetLife in a report on Wednesday, July 12th. Wells Fargo & Company reaffirmed a “buy” rating on shares of MetLife in a report on Thursday, May 4th. Zacks Investment Research raised MetLife from a “sell” rating to a “hold” rating in a report on Friday, May 5th. Finally, ValuEngine raised MetLife from a “buy” rating to a “strong-buy” rating in a report on Tuesday, June 27th. Two research analysts have rated the stock with a sell rating, six have issued a hold rating, seven have issued a buy rating and one has issued a strong buy rating to the company’s stock. The company presently has a consensus rating of “Hold” and a consensus price target of $59.02.

About MetLife

MetLife, Inc is a provider of life insurance, annuities, employee benefits and asset management. The Company’s segments include U.S.; Asia; Latin America; Europe, the Middle East and Africa (EMEA); MetLife Holdings; Brighthouse Financial, and Corporate & Other. Its U.S. segment is organized into Group Benefits, Retirement and Income Solutions and Property & Casualty businesses.

Want to see what other hedge funds are holding MET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for MetLife, Inc. (NYSE:MET).

Institutional Ownership by Quarter for MetLife (NYSE:MET)

Receive News & Ratings for MetLife Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife Inc. and related companies with MarketBeat.com's FREE daily email newsletter.